Workflow
德展大健康:5%以上股东股份拍卖过户及被动减持完成

Core Viewpoint - The announcement from 德展大健康股份有限公司 details the completion of share transfers involving significant shareholders, 上海岳野 and 美林控股, without affecting the company's control or operations [1][2][3]. Share Transfer Summary - 上海岳野 completed the auction transfer of 25,250,000 shares, representing 1.17% of the total share capital, reducing its holding from 19.13% to 17.96% [2]. - The shares were auctioned on the 京东 judicial auction platform, and the transfer was completed in compliance with legal regulations [2]. - The new shareholder is restricted from selling the acquired shares within six months [2]. Forced Reduction Summary - 美林控股 underwent a forced reduction of 15,127,500 shares due to a default in a stock pledge repurchase agreement, with a total of 21,363,800 shares executed, accounting for 0.99% of the total share capital [3]. - The forced execution price ranged from 3.15 to 3.48 yuan per share [3]. - 美林控股 is not a controlling shareholder, and this reduction will not impact the company's governance or operations [3]. Commitments and Compliance - 上海岳野 is fulfilling its commitment to reduce and regulate related party transactions without any violations [3]. - 美林控股 is also adhering to its commitments, although there is a dispute regarding performance commitments with 新疆凯迪投资, which has led to an arbitration application [3].